Skip to content

Instrumental assessment of movement disorders in antipsychotic naive patients with autism and healthy controls

Instrumental assessment of movement disorders in antipsychotic naive patients with autism and healthy controls - Movement disorders in autism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35557
Enrollment
100
Registered
2010-02-08
Start date
2010-08-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with autism -High functioning medication naïve patients diagnosed autism spectrum disorders according to DSM-IV codes 299.00 or 299.80 -Age 12-22 year: addendum 6-22;2. Healthy controls Healthy controls without psychiatric disorders according to DSM-IV code V71.09 -Age 12-22 year; addendum 6-22

Exclusion criteria

Exclusion criteria: -Use of antipsychotic medication, antidepressants or benzodiazepines, now or in the past. -A medical, psychiatric (other than autism spectrum disorder) and / or neurological disorder (with the exception of epilepsy) that can produces movement disorders. -DSM-criteria for substance abuse, other than nicotine of caffeine. -IQ

Design outcomes

Primary

MeasureTime frame
Difference in prevalences of instrumental assessment of movement disorders among drug naive patients with autism compared with matched healthy controls

Secondary

MeasureTime frame
Difference in prevalences of clinical assessment of movement disorders among drug naive patients with autism compared with matched healthy controls

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)